Biological aging measures: hopes and hypes for biogerontology
The abstract argues that aging clocks and circulating biomarkers improve biological-age estimation, but prediction alone does not show biological meaning or clinical utility; it calls for gerodiagnostic approaches to individual aging trajectories. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract links population aging to a search for biological measures explaining differences among people of the same chronological age. [1]
Aging clocks and circulating biomarkers improved biological-age estimation, but prediction alone does not establish biological meaning or clinical utility. [1]
The abstract proposes gerodiagnostic approaches to individual aging trajectories and their modifiability instead of single biomarkers and universal clocks. [1]
The source at a glance
- Study type / format
- Abstract of a conceptual commentary or perspective on biological aging measures
- Population / context
- People differing in health, function, resilience and disease burden at the same chronological age, as discussed in the abstract.
- Summary based on
- Study abstract
- Original publication
- September 26, 2026
Why biological age measures are sought
The abstract begins with population aging and the search for biological measures that explain why people of the same chronological age differ markedly in health, function, resilience and disease burden. Geroscience is described as a powerful framework linking shared aging mechanisms to multiple age-related conditions, yet translation to clinical practice remains incomplete.
Supporting source [1]
Clocks estimate age but do not prove utility
Aging clocks and circulating biomarkers have improved biological-age estimation. The abstract stresses that prediction alone does not establish biological meaning or clinical utility. It instead supports viewing aging as heterogeneous and multidimensional, shaped by organ-specific vulnerability, cumulative stress, multimorbidity and declining resilience.
Supporting source [1]
Proposed shift to gerodiagnostics and healthspan
The abstract proposes moving beyond single biomarkers and universal aging clocks toward gerodiagnostic approaches that characterize individual aging trajectories and their modifiability. It says progress in gerotherapeutics will require closer integration of mechanism, measurement and intervention. The stated goal is to identify actionable biological processes whose modification may preserve function, delay multimorbidity and extend healthspan, not merely to quantify aging.
Supporting source [1]
How to interpret this
This is based only on the abstract; the full text was not reviewed. The abstract reports no study design, sample, follow-up or outcome data, and its proposals are not validated clinical tools.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Marzetti E, Picca A. · europepmc.org · September 26, 2026